PRMT7 and chronic obstructive pulmonary disease: These data were confirmed by an in vivo study, in which Prmt7+/− mice exposed to cigarette smoke (CSE) showed less monocyte/macrophage infiltration in the lungs and were protected from chronic lung disease [21], suggesting the use of PRMT7 inhibitors as a possible therapeutic strategy to treat COPD.